Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yakir Rottenberg

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Cancer|November 13, 2018
Adolescent overweight and obesity and the risk for pancreatic cancer among men and women: a nationwide study of 1.79 million Israeli adolescentsLevi Zohar, Yakir Rottenberg, Gilad Twig, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 30, 2021
Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma modelRiccardo Serra, Antonella Mangraviti, Noah L Gorelick, et al.
Translational Lung Cancer Research|April 11, 2024
Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapyEyal Tsur, Philip Blumenfeld, Yakir Rottenberg, et al.
Oncoimmunology|February 8, 2021
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world dataElizabeth Dudnik, Mor Moskovitz, Yakir Rottenberg, et al.
Clinical Lung Cancer|January 17, 2022
dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50Liran Holtzman, Mor Moskovitz, Damien Urban, et al.
Cancers|October 14, 2023
Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA MutationsJohnathan Arnon, Michael Tabi, Yakir Rottenberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2019
Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancerTovi Shapira-Furman, Riccardo Serra, Noah Gorelick, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomicsJohnathan Arnon, Gal Dinstag, Omer Tirosh, et al.
Frontiers in Oncology|July 5, 2022
Liquid First Is "Solid" in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation SequencingOr Sehayek, Waleed Kian, Amir Onn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 4, 2025
Effective head and neck cancer treatment combines radiation and local extended cisplatin releaseNarmeen Daher-Ghanem, Shell Raveh, Awanish Kumar, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cancer|November 13, 2018
Adolescent overweight and obesity and the risk for pancreatic cancer among men and women: a nationwide study of 1.79 million Israeli adolescentsLevi Zohar, Yakir Rottenberg, Gilad Twig, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 30, 2021
Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma modelRiccardo Serra, Antonella Mangraviti, Noah L Gorelick, et al.
Translational Lung Cancer Research|April 11, 2024
Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapyEyal Tsur, Philip Blumenfeld, Yakir Rottenberg, et al.
Oncoimmunology|February 8, 2021
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world dataElizabeth Dudnik, Mor Moskovitz, Yakir Rottenberg, et al.
Clinical Lung Cancer|January 17, 2022
dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50Liran Holtzman, Mor Moskovitz, Damien Urban, et al.
Cancers|October 14, 2023
Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA MutationsJohnathan Arnon, Michael Tabi, Yakir Rottenberg, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2019
Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancerTovi Shapira-Furman, Riccardo Serra, Noah Gorelick, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomicsJohnathan Arnon, Gal Dinstag, Omer Tirosh, et al.
Frontiers in Oncology|July 5, 2022
Liquid First Is "Solid" in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation SequencingOr Sehayek, Waleed Kian, Amir Onn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 4, 2025
Effective head and neck cancer treatment combines radiation and local extended cisplatin releaseNarmeen Daher-Ghanem, Shell Raveh, Awanish Kumar, et al.
Pageof 7